believe that the use of DNA-based testing to determine the
likelihood of disease progression will initiate a new era of improvements
in spine health," says Jim Ogilvie, M.D, Chief Medical Consultant. "From a
clinical standpoint, this test delivers the promise of personalized
medicine to spine surgeons who will now have the opportunity to determine
the likely disease progression for an individual AIS patient, and can make
evidence-based recommendations for patient-specific treatment options."
Geneticists at Axial Biotech are currently analyzing the data from the
9,000 patients studied, to identify genetic factors that initially cause
this disease, and the company anticipates that soon it may largely
understand the specific biology for this aggressive and crippling disease,
and hopes to develop molecular treatments for scoliosis patients.
The AIS prognostic test will be marketed under the trade name of
ScoliScore(TM) and will be marketed and distributed by DePuy Spine, a
Johnson & Johnson company.
About Axial Biotech
Axial Biotech, Inc. develops molecular diagnostic assays and motion
preservation technologies for common spinal diseases and disorders. Axial
has developed the first DNA-based prognostic test for Adolescent Idiopathic
Scoliosis. Axial is accredited by the College of American Pathologists
(CAP) and is certified to comply with the Clinical Laboratory Improvement
Amendments (CLIA). Founded in 2002, Axial is based in Salt Lake City, Utah.
'/>"/>SOURCE Axial Biotech, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine technology :1.
K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers Grains2.
Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists3.
Dallas Researchers Find Compression Stockings Improperly Used4.
Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report5.
Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis6.
GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers7.
Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients8.
NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression9.
Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures10.
Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab11.
Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women